In a dramatic week of trading, The Numbers portfolio navigated the volatile waters of the stock market with mixed results. Over the week, the portfolio came tantalizingly close to matching the S&P 500’s climb but fell short by 0.34% as the overall fund eked out a modest gain of 0.73%.
The stars of this trading period were the energy and consumer staples sectors. The S&P 500 Energy Sector SPDR ETF delivered an impressive 7.21%, riding high on the back of oil price gains and investor optimism in the energy space. The Consumer Staples Sector SPDR ETF also fared well with a 5.10% return, as investors sought the relative safety of essentials during uncertain market conditions.
Tech and finance stocks also saw a mixture of outcomes. Mastercard and Intuit both glided upwards, bolstering the portfolio with returns of 6.93% and 8.52%, respectively. Mastercard’s stellar performance was likely influenced by positive spending trends and robust consumer demand. Meanwhile, Intuit benefited from its strong product suite and a thriving tax season.
Salesforce contributed positively with a 5.44% gain, likely buoyed by its consistent track record in enterprise software solutions. However, Costco’s barely-there 0.46% gain suggested the retail giant didn’t fully capitalize on the spending trend that benefitted other consumer-oriented stocks.
Not all sectors sang a winning tune, as certain tech and finance stocks faced headwinds. NVIDIA and Advanced Micro Devices saw downturns of 7.90% and 14.78%, respectively, possibly due to investors taking profits after strong previous rallies or concerns over semiconductor supply challenges and competition. Oracle and the VanEck Semiconductor ETF were the portfolio’s worst performers this week, nosediving 18.30% and 18.36% as tech stocks were pummeled under pressure from interest rate fears.
Even the financial stalwarts weren’t immune: Morgan Stanley and Goldman Sachs took hits of 8.50% and 12.22%, possibly from broader market turbulence and fluctuating economic indicators, suggesting investors are bracing for potential economic slowdowns. Eli Lilly and Company experienced a 9.02% decline, which might reflect a market reassessment of its valuation amid shifts in healthcare policies or competition.
In terms of performance success, the portfolio recorded a 54% hit rate for winning trades. It underscores the market’s current complexity, with strong sector-specific movements providing both formidable gains and daunting losses in rapid succession. While the path was riddled with challenges, potential opportunities glimmer as investors prepare for another unpredictable week in the markets.